Methylprednisolone, Valacyclovir, or the Combination for Vestibular Neuritis
Authors:
- Michael StruppMSMichael Strupp
- Vera Carina ZinglerVZVera Carina Zingler
- Viktor ArbusowVAViktor Arbusow
- Daniel NiklasDNDaniel Niklas
- Klaus Peter MaagKMKlaus Peter Maag
- Marianne DieterichMDMarianne Dieterich
- Sandra BenseSBSandra Bense
- Diethilde TheilDTDiethilde Theil
- Klaus JahnKJKlaus Jahn
- Thomas BrandtTBThomas Brandt
Top Cited Papers
Open Access
- 22 July 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (4) , 354-361
Abstract
Vestibular neuritis is the second most common cause of peripheral vestibular vertigo. Its assumed cause is a reactivation of herpes simplex virus type 1 infection. Therefore, corticosteroids, antiviral agents, or a combination of the two might improve the outcome in patients with vestibular neuritis. We performed a prospective, randomized, double-blind, two-by-two factorial trial in which patients with acute vestibular neuritis were randomly assigned to treatment with placebo, methylprednisolone, valacyclovir, or methylprednisolone plus valacyclovir. Vestibular function was determined by caloric irrigation, with the use of the vestibular paresis formula (to measure the extent of unilateral caloric paresis) within 3 days after the onset of symptoms and 12 months afterward. Of a total of 141 patients who underwent randomization, 38 received placebo, 35 methylprednisolone, 33 valacyclovir, and 35 methylprednisolone plus valacyclovir. At the onset of symptoms there was no difference among the groups in the severity of vestibular paresis. The mean (±SD) improvement in peripheral vestibular function at the 12-month follow-up was 39.6±28.1 percentage points in the placebo group, 62.4±16.9 percentage points in the methylprednisolone group, 36.0±26.7 percentage points in the valacyclovir group, and 59.2±24.1 percentage points in the methylprednisolone-plus-valacyclovir group. Analysis of variance showed a significant effect of methylprednisolone (P<0.001) but not of valacyclovir (P=0.43). The combination of methylprednisolone and valacyclovir was not superior to corticosteroid monotherapy. Methylprednisolone significantly improves the recovery of peripheral vestibular function in patients with vestibular neuritis, whereas valacyclovir does not.Keywords
This publication has 24 references indexed in Scilit:
- Latent Herpesvirus Infection in Human Trigeminal Ganglia Causes Chronic Immune ResponseThe American Journal of Pathology, 2003
- Vestibular NeuritisNew England Journal of Medicine, 2003
- Outcome of and Prognostic Factors for Herpes Simplex Encephalitis in Adult Patients: Results of a Multicenter StudyClinical Infectious Diseases, 2002
- Lesion‐induced plasticity in rat vestibular nucleus neurones dependent on glucocorticoid receptor activationThe Journal of Physiology, 1999
- Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcomeJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Progress of Caloric Response of Vestibular NeuronitisActa Oto-Laryngologica, 1993
- Latent Herpes Simplex Virus Type 1 in Human Vestibular GangliaActa Oto-Laryngologica, 1993
- Recovery of the Vestibular Function after Vestibular NeuronitisActa Oto-Laryngologica, 1993
- Vestibular Neuronitis: Epidemiological Survey by Questionnaire in JapanActa Oto-Laryngologica, 1993
- Some Cases of Ocular Nystagmus Due to Certain Positions of the HeadActa Oto-Laryngologica, 1924